Dr. Ayman Saleh
Dr. Ayman Saleh received his Ph.D. in Biochemistry and Molecular Biology from London Health Science Center at the University of Western Ontario, London, Ontario, Canada in 1998, then he went on to a 3-year post-doctoral fellowship under an NIH Training Grant in Kimmel Cancer Research Center at Thomas Jefferson University in Philadelphia to study the signal transduction of apoptosis. He was one of the pioneers to delineate the role of mitochondria in apoptosis. After that he held his first Assistant Professor and Senior Research Scientist position in the Faculty of Medicine and Health Sciences at the United Arab Emirates University for 4 years (2001-2005). Between 2010 and 2012, Dr. Saleh served as Associate Professor of Biochemistry and Molecular & Cellular Biology in Both Herbert Wertheim College of Medicine at Florida International University, Miami Florida, and Lake Erie College of Medicine and School of Pharmacy (LECOM), Erie Pennsylvania, USA. Subsequently, he joined King Saud Bin Abdulaziz University in 2012 as Associate Professor of Medical Biochemistry and Molecular Biology in the. He is also holding a Scientist position at King Abdullah International Medical Research Center. Dr. Saleh’s research is focused on signal transduction of diseases including cancer and neurodegeneration, and synthesis of novel anticancer agents. Dr. Saleh is an author of more than 54 research publications in molecular aspects of apoptosis, novel synthetic and natural anticancer and anti-neurodegeneration drugs, organophosphate toxicity, transcription regulation and medical enzymology. Dr. Saleh’s publications have been cited over than 4000 times.